期刊文献+

超声、X线、MRI诊断鉴别不同分子亚型乳腺癌价值评价 被引量:2

暂未订购
导出
摘要 目的 评价超声、X线、M RI诊断不同分子亚型乳腺癌的价值.方法 随机抽取2013年1月~2016年1月我院收治的乳腺癌患者70例,所有患者均进行X线、超声、MRI检查,按照不同分子亚型分为:Luminal A型组(n=18),Luminal B型组(n=27),Her2阳性型组(n=14),三阴性型组(n=11),统计X线、超声、MRI检查的符合率.结果 超声诊断的总符合率为91.4%,X线诊断的总符合率为78.6%,M RI诊断的总符合率为97.1%.三者相比较,M RI的诊断符合率高于X线和超声,P〈0.05,具有统计学差异.结论 相对于X线和超声检查,M RI检查对于不同分子亚型乳腺癌的诊断价值更高,值得临床应用进行借鉴.
作者 蔡春鸣
机构地区 唐河县人民医院
出处 《临床研究》 2017年第11期183-184,共2页 Clinical Research
  • 相关文献

参考文献4

二级参考文献48

  • 1El Khouli RH, Macura KJ, Kamel IR, et al. 3-T dynamic con-trast-enhanced MRI of the breast: Pharmacokinetic parametersversus conventional kinetic curve analysis. AJR Am J Roentgen-ol, 2011,197(.6):1498-1505.
  • 2Yu Y, Jiang Q, Miao Y, et al. , Quantitative analysis of clinicaldynamic contrast-enhanced MR imaging for evaluating treatmentresponse in human breast cancer. Radiology, 2010,257 (1) : 47-55.
  • 3徐慧,贾文霄,周梅.三阴性乳腺癌MR征象与病理学表现的相关性分析.中国医学影像技术,2010,26(增刊):31-34.
  • 4Lee SH, Cho N, Kim SJ, et al. Correlation between high resolu-tion dynamic MR features and prognostic factors in breast cancer.Korean J Radiol, 2008,9(1) :10-18.
  • 5Tofts PS, BrixG,Buckley DL, et al. Estimating kinetic parame-ters from dynamic contrast-enhanced T(l)-weighted MRI of a dif-fusable tracer: Standardized quantities and symbols. J Magn Re-son Imaging, 1999,10(3) :223-232.
  • 6Hammond ME, Hayes DF, Dowsett M, et al. American societyof clinical oncology/college of American pathologists guidelinerecommendations for immunohistochemical testing of estrogen andprogesterone receptors in breast cancer (unabridged version).Arch Pathol Lab Med, 2010,134(7) :e48-e72.
  • 7Li SP, Taylor NJ, Makris A, et al. Primary human breast adeno-carcinoma: Imaging and histologic correlates of intrinsic suscepti-bility-weighted MR imaging before and during chemotherapy. Ra-diology, 2010,257(3):643-652.
  • 8Pickles MD, Manton DJ, Lowry M, et al. Prognostic value ofpre-treatment DCE-MRI parameters in predicting disease free andoverall survival for breast cancer patients undergoing neoadjuvantchemotherapy. Eur J Radiol, 2009,71(3) :498-505.
  • 9Linderholm BK, Heilborg H, Johansson U, et al. Significantlyhigher levels of vascular endothelial growth factor (VEGF) andshorter survival times for patients with primary operable triple-negative breast cancer. Ann Oncol, 2009, 20( 10) : 1639-1646.
  • 10Foulkes WD, Brunet JS, Stefansson IM, et al. The prognosticimplication of the basal-like (cyclin E high/p27 low/p53 + /glo-meruloid-microvascular-proliferation + ) phenotype of BRCA1-related breast cancer. Cancer Res, 2004, 64(3) :830-835.

共引文献72

同被引文献19

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部